These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36910647)

  • 21. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
    Zuo MN; DU YQ; Yu LP; Dai X; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    Jiang C; Wang Y; Fu W; Zhang G; Feng X; Wang X; Wang F; Zhang L; Deng Y
    Front Nutr; 2022; 9():978110. PubMed ID: 36590214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is non-high-density lipoprotein associated with metabolic syndrome? A systematic review and meta-analysis.
    Mardi P; Abdi F; Ehsani A; Seif E; Djalalinia S; Heshmati J; Shahrestanaki E; Gorabi AM; Qorbani M
    Front Endocrinol (Lausanne); 2022; 13():957136. PubMed ID: 36176470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
    Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis.
    Yin Z; Fan X; Ye H; Yin D; Wang J
    Ann Surg Oncol; 2013 Apr; 20(4):1203-15. PubMed ID: 23099728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic immune-inflammation index and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta-analysis.
    Li D; Zhao X; Pi X; Wang K; Song D
    Clin Exp Med; 2023 Oct; 23(6):2105-2114. PubMed ID: 36287310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of circulating total bilirubin with the metabolic syndrome and type 2 diabetes: A systematic review and meta-analysis of observational evidence.
    Nano J; Muka T; Cepeda M; Voortman T; Dhana K; Brahimaj A; Dehghan A; Franco OH
    Diabetes Metab; 2016 Dec; 42(6):389-397. PubMed ID: 27396752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Li DZ; Guo J; Song QK; Hu XJ; Bao XL; Lu J
    Transl Cancer Res; 2022 Nov; 11(11):4037-4050. PubMed ID: 36523315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between metabolic syndrome and prognosis of breast cancer: a meta-analysis of follow-up studies.
    Li P; Wang T; Zeng C; Yang M; Li G; Han J; Wu W
    Diabetol Metab Syndr; 2020; 12():10. PubMed ID: 32015762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome; associations with adverse outcome after colorectal surgery. A systematic review and meta-analysis.
    Reudink M; Slooter CD; Janssen L; Lieverse AG; Roumen RMH; Slooter GD
    Ann Med Surg (Lond); 2021 Nov; 71():102997. PubMed ID: 34840752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: a systematic review and meta-analysis.
    Gadallah EA; Elkomos BE; Khalil A; Fawzy FS; Abdelaal A
    BMC Surg; 2023 Jan; 23(1):2. PubMed ID: 36600282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Major Food Sources of Fructose-Containing Sugars With Incident Metabolic Syndrome: A Systematic Review and Meta-analysis.
    Semnani-Azad Z; Khan TA; Blanco Mejia S; de Souza RJ; Leiter LA; Kendall CWC; Hanley AJ; Sievenpiper JL
    JAMA Netw Open; 2020 Jul; 3(7):e209993. PubMed ID: 32644139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
    Hung AK; Guy J
    World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Lin S; Hu S; Ran Y; Wu F
    Transl Cancer Res; 2021 Apr; 10(4):1667-1678. PubMed ID: 35116492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review.
    Wei Z; Zhao J; Bi X; Zhang Y; Zhou J; Li Z; Huang Z; Zhao H; Cai J
    Hepatobiliary Surg Nutr; 2022 Oct; 11(5):709-717. PubMed ID: 36268237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
    Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
    Zhang Y; Li Y; Jiang W; Li Q; Lan Y
    Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.